Awardee OrganizationMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Description
Abstract Text
Continuation Page Principal Investigator/ProgramDirector: Tannenbaum, Steven R.
Core 1. Analytical, Cell Culture, and Nitric Oxide Delivery.
A thread common to the projects in this Program is quantitation, and success depends strongly on accurate
and reproducible biological and bioanalytical experiments. The specific needs include dependable delivery
of oxidative damage agents, e.g., nitric oxide or peroxynitrite, stable and reliable cell cultures, and both
characterization and quantitative analysis of substances ranging from small, polar compounds such as
formaldehyde through nucleosides, peptides, and nucleic-acid oligomers, to intact proteins. Core 1 not only
provides these as services, assuring both consistency and continuity, but also works directly with Project
researchers as new methods become necessary or familiar methods require improvement. Facilities include
unique nitric oxide delivery systems (that were developed during previous funding periods as a collaboration
between Core 1and Project 1), centralized cell-culture facilities, and state-of-the-art chromatography and
mass spectrometry laboratories. The Core also provides training and supervision, again assuring lab-to-lab
consistency, e.g., in handling cell-lines, or in conducting LC/MS experiments. Core 1 is used by all four
Projects (although this is indirect via interaction with Projects 2 and 3 in the case of Project 4). Project 1
focuses on the behavior of inflammation-related active species and uses the cell culture facilities and both
develops and uses the delivery systems; Projects 2 and 3 use these facilities as well, but also make
extensive use of the bioanalytical facilities, e.g., tandem quadrupole mass spectrometry for quantitation in
Project 2 and electrospray time-of-flight mass spectrometry for characterization of synthetic and modified
DNA oligomers in Project 3. Key personnel include Dr. John S. Wishnok as overall director of the Core and
Ms. Laura Trudel who oversees the cell culture and nitric oxide delivery facilities.
No Sub Projects information available for 2P01CA026731-30 7987
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P01CA026731-30 7987
Patents
No Patents information available for 2P01CA026731-30 7987
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P01CA026731-30 7987
Clinical Studies
No Clinical Studies information available for 2P01CA026731-30 7987
News and More
Related News Releases
No news release information available for 2P01CA026731-30 7987
History
No Historical information available for 2P01CA026731-30 7987
Similar Projects
No Similar Projects information available for 2P01CA026731-30 7987